
浏览全部资源
扫码关注微信
暨南大学附属第一医院眼科,广东 广州 510630
王美岚,第一作者,研究方向:白内障,E-mail: wml9803@163.com
纸质出版日期:2024-11-20,
收稿日期:2024-06-27,
录用日期:2024-10-07
移动端阅览
王美岚,刘莲.乳酸菌在眼科的应用潜力[J].中山大学学报(医学科学版),2024,45(06):953-960.
WANG Meilan,LIU Lian.Application Potential of Lactic Acid Bacteria in Ophthalmology[J].Journal of Sun Yat-sen University(Medical Sciences),2024,45(06):953-960.
王美岚,刘莲.乳酸菌在眼科的应用潜力[J].中山大学学报(医学科学版),2024,45(06):953-960. DOI: 10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).20241021.006.
WANG Meilan,LIU Lian.Application Potential of Lactic Acid Bacteria in Ophthalmology[J].Journal of Sun Yat-sen University(Medical Sciences),2024,45(06):953-960. DOI: 10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).20241021.006.
乳酸菌具有营养、抑菌、免疫调节等生物学功能,在食品、农牧业、工业、医药等领域中发挥重要作用。目前乳酸菌在临床应用研究中,关注焦点集中于胃肠道疾病、泌尿道感染、慢性鼻炎、抗肿瘤等,却鲜有介绍乳酸菌在眼部应用的研究进展。乳酸菌治疗眼病的作用机制除了通过调节炎症外,还可通过直接作用或间接作用机制治疗眼病。本文通过回顾乳酸菌在眼表疾病、真菌性角膜炎、晶状体和视网膜等疾病的应用,按乳酸菌株及其相关机制进行归纳和总结,比较不同的乳酸菌株治疗眼科疾病的差异,总结了乳酸菌在眼部研究中的体外、体内及临床证据,使用乳酸菌治疗具有较高安全性。对眼科疾病的应用展现出显著的创新性和临床意义,拓宽了乳酸菌在眼科的应用范围,为未来的临床治疗提供了新的思路。
Lactic acid bacteria(LAB) have biological functions such as nutrition, bacteriostasis and immune regulation, which play important roles in the fields of food, agriculture and animal husbandry, industry, medicine and so on. At present, in the clinical application research of LAB, the focus of attention is on gastrointestinal diseases, urinary tract infections, allergic rhinitis, anti-tumor, etc., but there are few introductions to the research progress of LAB in ocular application. In addition to regulating inflammation, the mechanism of action of lactic acid bacteria in the treatment of eye diseases is also affected by different mechanisms, which can be divided into direct and indirect effects. This article reviews the application of lactic acid bacteria in ocular surface diseases, fungal keratitis, lens and retinal diseases, summarizes and summarizes lactic acid strains and their related mechanisms, compares the differences of different lactic acid strains in the treatment of ophthalmic diseases. The in vitro, in vivo and clinical evidence of lactic acid bacteria in ophthalmic research are summarized, and the use of lactic acid bacteria in the treatment has high safety. The application of ophthalmic diseases has shown significant innovation and clinical significance, broadened the application scope of lactic acid bacteria in ophthalmology, and provided new ideas for future clinical treatment.
乳酸菌直接作用间接作用眼科疾病治疗
lactic acid bacteriadirect effectindirect effectophthalmic diseasestherapy
Tian X, Chen H, Liu H, et al. Recent advances in lactic acid production by lactic acid bacteria[J]. Appl Biochem Biotechnol, 2021, 193(12): 4151-4171.
Masood MI, Qadir MI, Shirazi JH, et al. Beneficial effects of lactic acid bacteria on human beings[J]. Crit Rev Microbiol, 2011, 37(1): 91-98
Bermudez-Brito M, Plaza-Díaz J, Muñoz-Quezada S, et al. Probiotic mechanisms of action[J]. Ann Nutr Metab, 2012, 61(2): 160-174.
曾珠. 乳酸菌作为药物分子粘膜投递载体的研究进展[J]. 生物工程学报, 2021, 37(7): 2272-2282.
Zeng Z. Advances in the use of lactic acid bacteria as mucosal delivery vectors of therapeutic molecules[J]. Chin J Biotechnol, 2021,37(07):2272-2282.
Liu Z, Xu C, Tian R, et al. Screening beneficial bacteriostatic lactic acid bacteria in the intestine and studies of bacteriostatic substances[J]. J Zhejiang Univ Sci (B), 2021, 22(7): 533-547.
Er S, İstanbullu Tosun A, Arik G, et al. Anticandidal activities of lactic acid bacteria isolated from the vagina[J]. Turk J Med Sci, 2019, 49(1): 375-383.
De Boeck I, Spacova I, Vanderveken OM, et al. Lactic acid bacteria as probiotics for the nose?[J]. Microb Biotechnol, 2021, 14(3): 859-869.
Wang G, Si Q, Yang S, et al. Lactic acid bacteria reduce diabetes symptoms in mice by alleviating gut microbiota dysbiosis and inflammation in different manners[J]. Food & Function, 2020, 11(7): 5898-5914.
Vinasco K, Mitchell HM, Kaakoush NO, et al. Microbial carcinogenesis: lactic acid bacteria in gastric cancer[J]. Biochim Biophys Acta Rev Cancer, 2019, 1872(2): 188309.
林育安, 张玉洁 石珂, 等. 眼表菌群与眼表疾病关系的研究进展[J]. 眼科学报, 2022, 37(5): 408-415.
Lin YA, Zhang YJ, Shi K, et al. Research progress on the relationship between ocular surface microbiota and ocular surface diseases[J]. Eye Sci, 2022, 37(5): 408-415.
Moon J, Ryu JS, Kim JY, et al. Effect of IRT5 probiotics on dry eye in the experimental dry eye mouse model[J]. PloS One, 2020, 15(12): e0243176.
Gerritsen J, Smidt H, Rijkers GT, et al. Intestinal microbiota in human health and disease: the impact of probiotics[J]. Genes Nutr, 2011, 6(3): 209-240.
Chisari G, Chisari EM, Francaviglia A, et al. The mixture of bifidobacterium associated with fructo-oligosaccharides reduces the damage of the ocular surface[J]. Clin Ter, 2017, 168(3): e181-e185.
Feher J, Pacella F, Turchetti P. Eye on the gut: irritable eye syndrome[J]. Clin Ter, 2020, 170(1): e87-e88.
Feher J, Pinter E, Kovács I, et al. Irritable eye syndrome: neuroimmune mechanisms and benefits of selected nutrients[J]. Ocul Surf, 2014, 12(2): 134-145.
Kugadas A, Wright Q, Geddes-McAlister J, et al. Role of microbiota in strengthening ocular mucosal barrier function through secretory IgA[J]. Invest Ophthalmol Vis Sci, 2017, 58(11): 4593-4600.
Yun SW, Son YH, Lee DY, et al. Correction: lactobacillus plantarum and bifidobacterium bifidum alleviate dry eye in mice with exorbital lacrimal gland excision by modulating gut inflammation and microbiota[J]. Food Funct, 2024, 15(2): 1051.
Yoon CH, Ryu J S, Moon J, et al. Association between aging-dependent gut microbiome dysbiosis and dry eye severity in C57BL/6 male mouse model: a pilot study[J]. BMC Microbiol, 2021, 21(1): 106.
Kim J, Choi SH, Kim YJ, et al. Clinical effect of IRT-5 probiotics on immune modulation of autoimmunity or alloimmunity in the eye[J]. Nutrients, 2017, 9(11): 1166.
Choi SH, Oh JW, Ryu JS, et al. IRT5 probiotics changes immune modulatory protein expression in the extraorbital lacrimal glands of an autoimmune dry eye mouse model[J]. Invest Ophthalmol Vis Sci, 2020, 61(3): 42.
Layús BI, Gomez MA, Cazorla SI, et al. Drops of lactiplantibacillus plantarum CRL 759 culture supernatant attenuates eyes inflammation induced by lipopolysaccharide[J]. Beneficial Microbes, 2021, 12(2): 163-174.
Morita Y, Jounai K, Miyake M, et al. Effect of heat-killed lactobacillus paracasei KW3110 ingestion on ocular disorders caused by visual display terminal (VDT) loads: a randomized, double-blind, placebo-controlled parallel-group study[J]. Nutrients, 2018, 10(8): 1058.
Heydari M, Kalani M, Ghasemi Y, et al. The effect of ophthalmic and systemic formulations of latilactobacillus sakei on clinical and immunological outcomes of patients with dry eye disease: a factorial, randomized, placebo-controlled, and triple-masking clinical trial[J]. Probiotics Antimicrob Proteins, 2024, 16(3): 1026-1035.
Inic-kanada A, Stojanovic M, Marinkovic E, et al. A probiotic adjuvant lactobacillus rhamnosus enhances specific immune responses after ocular mucosal immunization with chlamydial polymorphic membrane protein C[J]. Plos One, 2016, 11(9): e0157875.
Iovieno A, Lambiase A, Sacchetti M, et al. Preliminary evidence of the efficacy of probiotic eye-drop treatment in patients with vernal keratoconjunctivitis[J]. Graefes Arch Clin Exp Ophthalmol, 2008, 246(3): 435-441.
Nagata Y, Yoshida M, Kitazawa H, et al. Improvements in seasonal allergic disease with Lactobacillus plantarum No. 14[J]. Biosci Biotechnol Biochem, 2010, 74(9): 1869-1877.
Yamashita M, Kobatake E, Obuchi S, et al. Intake safety of Lactobacillus helveticus SBT2171 and its effects on nasal and ocular symptoms associated with mites and house dust: an open-label study and a randomized, double-blind, placebo-controlled, parallel group study[J]. Funct Foods Health Dis, 2019, 9(1): 52.
Kakiyama S, Kubota N, Shida K, et al. Effects of citrus juice fermented with Lactobacillus plantarum YIT 0132 on Japanese cedar pollinosis during probiotic consumption: an open study[J]. Biosci Microbiota Food Health, 2020, 39(3): 137-144.
Mills B, Radhakrishnan N, Karthikeyan Rajapandian SG, et al. The role of fungi in fungal keratitis[J]. Experim Eye Res, 2021, 202: 108372.
Wang F, Xin C, Liu J, et al. Interactions between invasive fungi and symbiotic bacteria[J]. World J Microbiol Biotechnol, 2020, 36(9): 137.
Akova B, Kivanç SA, Kivanç M. Antibiofilm effect of probiotic lactic acid bacteria against Bacillus spp obtained from the ocular surface[J]. Europ Rev Med Pharmacol Sci, 2021, 25(24): 7799-7805.
Hu J, Chen F, Kan T, et al. Inhibition of fusarium solani infection in murine keratocytes by Lactobacillus salivarius ssp. salivarius JCM1231 culture filtrate in vitro[J]. Curr Eye Res, 2017, 42(10): 1339-1347.
Nagashima H, Sasaki N, Amano S, et al. Oral administration of resveratrol or lactic acid bacterium improves lens elasticity[J]. Scient Rep, 2021, 11(1): 2174.
Hu C, Tang L, Liu M, et al. Probiotic modulation of perfluorobutanesulfonate toxicity in zebrafish: disturbances in retinoid metabolism and visual physiology[J]. Chemosphere, 2020, 258: 127409.
Morita Y, Miwa Y, Jounai K, et al. Lactobacillus paracasei KW3110 prevents blue light-induced inflammation and degeneration in the retina[J]. Nutrients, 2018, 10(12): 1991.
Morita Y, Jounai K, Sakamoto A, et al. Long-term intake of Lactobacillus paracasei KW3110 prevents age-related chronic inflammation and retinal cell loss in physiologically aged mice[J]. Aging, 2018, 10(10): 2723-2740.
Verma A, Zhu P, Xu K, et al. Angiotensin-(1-7) expressed from Lactobacillus bacteria protect diabetic retina in mice[J]. Transl Vis Sci Technol, 2020, 9(13): 20.
Yamazaki T, Suzuki H, Yamada S, et al. Lactobacillus paracasei KW3110 suppresses inflammatory stress-induced premature cellular senescence of human retinal pigment epithelium cells and reduces ocular disorders in healthy humans[J]. Internat J Mol Sci, 2020, 21(14): 5091.
Dickens A. Posttraumatic endophthalmitis caused by Lactobacillus[J]. Arch Ophthalmol, 1993, 111(9): 1169.
Papaconstantinou D, Georgalas I, Karmiris T, et al. Acute onset lactobacillus endophthalmitis after trabeculectomy: a case report[J]. J Med Case Rep, 2010, 4: 203.
0
浏览量
27
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621